123 related articles for article (PubMed ID: 12732383)
1. Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism.
Hayashi T; Sumi D; Matsui-Hirai H; Fukatsu A; Arockia Rani P J; Kano H; Tsunekawa T; Iguchi A
Atherosclerosis; 2003 May; 168(1):23-31. PubMed ID: 12732383
[TBL] [Abstract][Full Text] [Related]
2. Estriol retards and stabilizes atherosclerosis through an NO-mediated system.
Kano H; Hayashi T; Sumi D; Matusi-Hirai H; Tsunekawa T; Endo H; Iguchi A
Life Sci; 2002 May; 71(1):31-42. PubMed ID: 12020746
[TBL] [Abstract][Full Text] [Related]
3. Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism.
Hayashi T; Matsui-Hirai H; Fukatsu A; Sumi D; Kano-Hayashi H; Rani P JA; Iguchi A
Atherosclerosis; 2006 Aug; 187(2):316-24. PubMed ID: 16325187
[TBL] [Abstract][Full Text] [Related]
4. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
[TBL] [Abstract][Full Text] [Related]
5. A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits.
Hayashi T; Rani P JA; Fukatsu A; Matsui-Hirai H; Osawa M; Miyazaki A; Tsunekawa T; Kano-Hayashi H; Iguchi A; Sumi D; Ignarro LJ
Atherosclerosis; 2004 Oct; 176(2):255-63. PubMed ID: 15380447
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits.
Hayashi T; Sumi D; Juliet PA; Matsui-Hirai H; Asai-Tanaka Y; Kano H; Fukatsu A; Tsunekawa T; Miyazaki A; Iguchi A; Ignarro LJ
Cardiovasc Res; 2004 Feb; 61(2):339-51. PubMed ID: 14736551
[TBL] [Abstract][Full Text] [Related]
7. Crocetin improves endothelium-dependent relaxation of thoracic aorta in hypercholesterolemic rabbit by increasing eNOS activity.
Tang FT; Qian ZY; Liu PQ; Zheng SG; He SY; Bao LP; Huang HQ
Biochem Pharmacol; 2006 Aug; 72(5):558-65. PubMed ID: 16876766
[TBL] [Abstract][Full Text] [Related]
8. Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.
Wang YX; Martin-McNulty B; Huw LY; da Cunha V; Post J; Hinchman J; Vergona R; Sullivan ME; Dole W; Kauser K
Atherosclerosis; 2002 May; 162(1):23-31. PubMed ID: 11947894
[TBL] [Abstract][Full Text] [Related]
9. Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats.
Hironaka E; Hongo M; Sakai A; Mawatari E; Terasawa F; Okumura N; Yamazaki A; Ushiyama Y; Yazaki Y; Kinoshita O
Cardiovasc Res; 2003 Dec; 60(3):692-9. PubMed ID: 14659815
[TBL] [Abstract][Full Text] [Related]
10. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
Miyazaki M; Higashi Y; Goto C; Chayama K; Yoshizumi M; Sanada H; Orihashi K; Sueda T
J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
Kodama A; Komori K; Kajikuri J; Itoh T
J Vasc Surg; 2009 Sep; 50(3):617-25. PubMed ID: 19700096
[TBL] [Abstract][Full Text] [Related]
13. Anti-atherosclerotic effect of beta-blocker with nitric oxide-releasing action on the severe atherosclerosis.
Thakur NK; Hayashi T; Sumi D; Kano H; Matsui-Hirai H; Tsunekawa T; Iguchi A
J Cardiovasc Pharmacol; 2002 Feb; 39(2):298-309. PubMed ID: 11791016
[TBL] [Abstract][Full Text] [Related]
14. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits.
Ozer NK; Negis Y; Aytan N; Villacorta L; Ricciarelli R; Zingg JM; Azzi A
Atherosclerosis; 2006 Jan; 184(1):15-20. PubMed ID: 15979077
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide.
Hayashi T; Esaki T; Muto E; Kano H; Asai Y; Thakur NK; Sumi D; Jayachandran M; Iguchi A
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):782-92. PubMed ID: 10712404
[TBL] [Abstract][Full Text] [Related]
17. l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits.
Hayashi T; Juliet PA; Matsui-Hirai H; Miyazaki A; Fukatsu A; Funami J; Iguchi A; Ignarro LJ
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13681-6. PubMed ID: 16157883
[TBL] [Abstract][Full Text] [Related]
18. Suppression of high lipid diet induced by atherosclerosis sarpogrelate.
Xu YJ; Zhang M; Ji L; Elimban V; Chen L; Dhalla NS
J Cell Mol Med; 2012 Oct; 16(10):2394-400. PubMed ID: 22348587
[TBL] [Abstract][Full Text] [Related]
19. Effect of sarpogrelate, a selective 5-HT
Lee DH; Chun EJ; Hur JH; Min SH; Lee JE; Oh TJ; Kim KM; Jang HC; Han SJ; Kang DK; Kim HJ; Lim S
Atherosclerosis; 2017 Feb; 257():47-54. PubMed ID: 28068560
[TBL] [Abstract][Full Text] [Related]
20. Physiological concentration of 17beta-estradiol retards the progression of severe atherosclerosis induced by a high-cholesterol diet plus balloon catheter injury: role of NO.
Hayashi T; Jayachandran M; Sumi D; Thakur NK; Esaki T; Muto E; Kano H; Asai Y; Iguchi A
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1613-21. PubMed ID: 10845880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
